BRIDGEBIO PHARMA INC. - COMMON STOCK
23.42
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.18
+0.77%
Today's range
22.47 - 23.65
ISIN
N/A
Source
NASDAQ
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2024 16:31:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the 45th Annual Goldman Sachs Global Healthcare Conference
06 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
04 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
03 Jun 2024 16:01:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
14 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
13 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
02 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
02 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10 Apr 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
20 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
05 Mar 2024 23:53:56 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04 Mar 2024 16:17:36 By Nasdaq GlobeNewswire
-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
04 Mar 2024 02:30:00 By Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
22 Feb 2024 07:30:00 By Nasdaq GlobeNewswire